Ingevity’s Strategic Shift: Plant Closures and Financial Impact Amid Performance Chemicals Overhaul
Company Announcements

Ingevity’s Strategic Shift: Plant Closures and Financial Impact Amid Performance Chemicals Overhaul

Ingevity (NGVT) has disclosed a new risk, in the Corporate Activity and Growth category.

Ingevity’s strategic repositioning of its Performance Chemicals segment, announced on November 1, 2023, and July 31, 2024, involves significant operational changes, including the closure of plants in DeRidder, Louisiana, and Crossett, Arkansas. This initiative aims to improve profitability and reduce cyclicality by decreasing exposure to lower-margin markets, impacting approximately 45% of the industrial specialties product line’s historical net sales. However, this transition is expected to incur substantial charges totaling approximately $350 million, of which $250 million are non-cash, potentially affecting the company’s financial health and operational outcomes. The anticipated financial implications are subject to various assumptions and risks, with the possibility of unforeseen material charges arising, which could further strain Ingevity’s financial condition during this period.

The average NGVT stock price target is $47.75, implying 14.26% upside potential.

To learn more about Ingevity’s risk factors, click here.

Related Articles
TheFlyIngevity price target raised to $47 from $40 at BMO Capital
TipRanks Auto-Generated NewsdeskIngevity Reports Q3 2024 Financial Performance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App